Suchergebnisse - "Babazono, Tetsuya"

PubPharm (253)

1

Comparative effects of sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors on kidney function decline in Japanese individuals with type 2 diabetes

enthalten in: Clinical and experimental nephrology | 2024

von Yoshida, N. | Hanai, K. | Babazono, T.

2

Clinical factors associated with birth weight of infants born to pregnant women with diabetes

enthalten in: Diabetology international | 2024

von Suzuki, T. | Yanagisawa, K. | Kakogawa, J. | +1

3

Effects of simultaneous pancreas and kidney transplantation in Japanese individuals with type 1 diabetes and end-stage kidney disease

enthalten in: Diabetology international | 2024

von Mori, T. | Nyumura, I. | Hanai, K. | +2

4

Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes

enthalten in: Diabetology international | 2024

von Oya, J. | Nakagami, T. | Hasegawa, Y. | +6

5

Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Mochizuki, S. | Miura, J. | Takagi, S. | +3

6

Effects of simultaneous pancreas and kidney transplantation in Japanese individuals with type 1 diabetes and end-stage kidney disease

enthalten in: Diabetology international | 2024

von Mori, T. | Nyumura, I. | Hanai, K. | +2

7

Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes

enthalten in: Diabetology international | 2024

von Oya, J. | Nakagami, T. | Hasegawa, Y. | +6

8

Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes : a historical cohort study

enthalten in: Clinical and experimental nephrology | 2023

von Babazono, T. | Hanai, K. | Yokoyama, Y. | +1

9

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6) : a phase 3a, randomised, open-label, treat-to-target trial

enthalten in: Lancet (London, England) | 2023

von Russell-Jones, D. | Babazono, T. | Cailleteau, R. | +7

CommentIn: Lancet. 2023 Nov 4;402(10413):1598-1599. - PMID 37863082

10

Lost in translation : assessing the nomenclature change for diabetic kidney disease in Japan

enthalten in: Diabetology international | 2023

von Babazono, T. | Moriya, T.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]